The current valuation score of Johnson & Johnson is 9.49, ranking 16 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 29.67, which is 17.71% below the recent high of 34.92 and 68.10% above the recent low of 9.47.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.